Skip to main content

Table 3 Frequency of fractures among ADT users and nonusers by extent of disease

From: Risk of fracture in men with prostate cancer on androgen deprivation therapy: a population-based cohort study in New Zealand

 

Any fracture

Hip fracture

Vertebral fracture

Localised

 No ADT (N = 3638)

63 (1.7 %)

7 (0.2 %)

10 (0.3 %)

 Any ADT (N = 172)

10 (5.8 %)

2 (1.2 %)

2 (1.2 %)

Locally advanced or Metastatic

 No ADT (N = 1404)

71 (5.1 %)

6 (0.4 %)

16 (1.1 %)

 Any ADT (N = 1707)

335 (19.6 %)

43 (2.5 %)

19 (1.1 %)

Unknown

 No ADT (N = 11,125)

390 (3.5 %)

107 (1.0 %)

110 (1.0 %)

 Any ADT (N = 7498)

669 (8.9 %)

173 (2.3 %)

116 (1.6 %)

  1. ADT androgen deprivation therapy